Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
11/06/2026 06:33
BRIEF-Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan June 11 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS:
ASTRAZENECA PHARMA - RECEIVED PERMISSION TO IMPORT FOR SALE OF TRASTUZUMAB DERUXTECAN
Source text: ID:nBSE6vFWJS
Further company coverage: ASTR.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan